Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

Clinical trial NCT01252199 · COMPLETED

Trial details

NCT number: NCT01252199
Sponsor: Thallion Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Shiga Toxin Producing Bacterial Infection

Start date: 2010-11-01
Primary completion: 2012-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.